StageBio, a leading international provider of GLP-compliant research, preclinical and clinical histopathology and biospecimen archiving services for the life sciences industry, announces that Ms. Kimberly Uptgraft has been appointed to Senior Vice President, Operations of StageBio.
The StageBio team is looking forward to sponsoring the American College of Toxicology’s annual meeting this year in Denver, Colorado on November 13-16 2022.
The StageBio team is looking forward to sponsoring ACVP this year in Boston, MA, November 12-15. Join the StageBio team as they host the opening reception Saturday, November 12 from 7:30-9pm. All attendees are welcome to attend and can expect to build in person connections while enjoying complimentary appetizers and refreshments.
StageBio, a leading international provider of GLP-compliant research, preclinical and clinical histopathology and biospecimen archiving services for life sciences industry, announces that Ms. Lecia Johnson has been appointed to Vice President, Commercial of StageBio.
The StageBio team is looking forward to exhibiting and attending The 19th European Congress of Toxicologic Pathology (ESTP). Attendees will have access to new research, educational and professional development programming, and networking opportunities for anyone working in the area of the female reproductive system and in toxicologic pathology.
The StageBio team is looking forward to attending the 2022 ESMO Congress Exhibition conference in Paris, France September 9-13, 2022.
Upgraded technology now enables StageBio to service clients in Europe.
It is with great honor that we congratulate Melanie Willis, CVT, BS, RQAP-GLP, Senior Quality Assurance Auditor, she has been elected as the inaugural SQA Director for Diversity, Inclusion, and Belonging.
StageBio is honored to introduce Lori A. Wright, RQAP-GLP, Senior Director, Quality and Regulatory.
StageBio is honored to introduce Dr. Juliana Lee, BVSc, MS, DACVP as Interim Director, Medical Device Pathology.
513.204.4400
